Prolacta Bioscience
Highly Engaged Employees
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1800 Highland Ave, Duarte, California, 9...Phone Number
(626) 599-9260Website
www.prolacta.comRevenue
$101.3 MillionIndustry
About Prolacta Bioscience
Prolacta Bioscience Org Chart
Is Prolacta Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Prolacta Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Prolacta Bioscience launches new products
Earning: See what the market has to say on Prolacta Bioscience recently announced quarterly report
Check if Prolacta Bioscience has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Prolacta Bioscience
Check out if Prolacta Bioscience is spiking on competitors!
Click to see if Prolacta Bioscience had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Prolacta Bioscience has new funding data
Recommended Actions
Reach out to Masked Content who joined Prolacta Bioscience as Masked Content
Find 2 more new buyers
Compare Similar Companies to Prolacta Bioscience
Compare insights from companies similar to Prolacta Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Prolacta Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Prolacta Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Prolacta Bioscience.
Prolacta Bioscience financials insights
Gather financial insights about Prolacta Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$811K
Series B
$5M
Series C
$12M
Private Equity
$5.8M
Series D
$15M
Private Equity
$35M
Prolacta Bioscience Tech Stack
A closer look at the technologies used by Prolacta Bioscience
Most Recent Scoops
Prolacta Bioscience News & Media
A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
Japan's Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU DUARTE, Calif., Feb. 18, 2026 /PRNewswire/ -- Prolacta Bioscience® today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved...Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan
Clinigen obtained approval for Prolacta's "PreemieFort® Enteral Solution", a human milk-based fortifier, as an approved pharmaceutical product in Japan indicated for the "Nutritional management of neonates and infants presenting with weight gain failure such as very low birth weight (VLBW) infants." The approval was supported by data from the pivotal Japan-based JASMINE Phase III clinical trial, a randomised, open-label, parallel-group comparison study in VLBW infants. This first-of-its kind appClinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan
Clinigen obtained approval for Prolacta's "PreemieFort® Enteral Solution", a human milk-based fortifier, as an approved pharmaceutical product in Japan indicated for the "Nutritional management of neonates and infants presenting with weight gain failure such as very low birth weight...Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants
Prolacta Offers the Only Nutritional Products Free From Cow Milk and Added Synthetic Ingredients Like Corn Syrup for Extremely Premature Infants in the U.S. DUARTE, Calif., Nov. 18, 2025 /PRNewswire/ -- Prolacta Bioscience® is celebrating Prematurity Awareness Month with a significant...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Prolacta Bioscience
Founded in 1999 and headquartered in Duarte, California, Prolacta Bioscience® Inc. is a privately held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world's leading hospital provider of 100% human milk-based nutritional products.... Read More


